当前位置: 首页 > 期刊 > 《中国实用医药》 > 2010年第14期
编号:11937290
脂联素与代谢综合征(4)
http://www.100md.com 2010年5月15日 《中国实用医药》 2010年第14期
     [10] 杜鹏飞,徐敏,洪洁,等.脂联素基因多态性与胰岛素抵抗的相关性研究.中华糖尿病杂志,2004,12(6):393-396.

    [11] Salmenniemi U.Zacharova J,Ruotsalainen E,et al.Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure, and cytokines in offspring of type 2 diabetic patients. J Clin Endocrinol Metnb,2005,90(7):4216-4223.

    [12] Ohashi K,Ouchi N,Kihara S,et al.Adiponectin l164T mutation is associated with the metabolic syndrome and coronary heart disease.J Am Coll Cardio1.2004,43(7):1195-200.
, http://www.100md.com
    [13] Vimaleswaran KS, Radha V, Ramya K,et al.A novel association of a polymorphism in the first intron of adiponectin gene with type 2 diabetes, obesity and hypoadiponectinemia in Asian Indians.Hum Genet,2008,123(6):599-605.

    [14] Patel S, Flyvbjerg A, Koza`kova` M, Frystyk J, Ibrahim IM, Petrie JR, Avery PJ, Ferrannini E, Walker M, the RISC Investigators. Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. Eur Heart J,2008,29:386-393. First published on December 15, 2007. doi:10.1093/eurheartj/ehm526.
, http://www.100md.com
    [15] Walker M, Patel S,et al. Association between the C-11377G promoter variant of the ACDC gene and carot intima thickness in healthy subjects. Diabetologia,2006,49(suppll):212-213.

    [16] Hoefle G, Muendlein A, Saely CH,et al.The -11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men.Thromb Haemost,2007,97(3):451-457.

    [17] Vasseur F, Helbecque N, Dina C,et al.Plasma concentrations of a novel adipose-specific protein, adiponectin, in type 2 diabetic patients.Arterioscl Thromb Vase Biol,2000,20:1595-1599.
, http://www.100md.com
    [18] Sun H, Gong ZC, Yin JY,et al.The association of adiponectin allele 45T/G and -11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients.Br J Clin Pharmacol,2008,65(6):917-926.

    [19] Ryu SY, Kim KS, Park J, Kang MG, Han MA,et al.The association between circulating inflammatory markers and metabolic syndromein Korean rural adults.J Prev Med Public Health,2008,41(6):413-418.

    [20] Xydakist AM, Case CC, Jones PH,et al.adiponectin,imflammation,and the expression,of the metabolic syndrome in obese individuals:the impact of rapid eight 1oss through caloric restriction.Journal of Clinical Endocrinology & Metabolism,2004,89:2697- 2703.
, http://www.100md.com
    [21] Hung J, McQuillan BM, Thompson PL,et al.Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.Int J Obes (Lond),2008,32(5):772-779.

    [22] Hotta K,Funahashi T,Bodkin NL,et al.Circulating congcentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.Diabetes,2001,50:1126-1133.

    [23] Milan G,Granzotto M,Scarda A,et al.Resistin and adiponecin expression in visceral fat of obese rats:effect of weight loss.Obes Res,2002,10(11):1095-1103.

    , 百拇医药(蒋海彬 施亚雄)
上一页1 2 3 4 5 6 7下一页